Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

NCT00984139

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Pforzheim, Baden-Wurttemberg, Germany
View all 24 locations
View Trial Details
Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

NCT00197184

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Barcelona, Spain
View Trial Details
Completed

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bindlach, Bavaria, Germany
  • GSK Investigational Site Kirchheim, Bavaria, Germany
View Trial Details
Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Banská Bystrica, Slovakia
  • GSK Investigational Site Dolný Kubín, Slovakia
  • GSK Investigational Site Dubnica nad Váhom, Slovakia
  • GSK Investigational Site Martin, Slovakia
View Trial Details
Completed

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • GSK Investigational Site Birkenfeld, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

NCT02167113

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Banner Health Good Samaritan Phoenix, Arizona, United States
  • Dignity Health - St. Joseph's Hospital Phoenix, Arizona, United States
  • Advanced Rx Clinical Research Garden Grove, California, United States
  • High Desert Gastroenterology Lancaster, California, United States
View all 90 locations
View Trial Details

Related conditions